Alembic Pharmaceuticals on Thursday said it has received final approval from the US health regulator for its generic version of  Paclitaxel injection used in the treatment of certain
Share this article
If you liked this article share it with your friends.they will thank you later
/newsdrum-in/media/post_banners/1T1XaeznXr3XrHSkVxYN.jpg)
1 Min read
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg){kind=logo}
